Skip Nav Destination
1-7 of 7
Cancer Res (2017) 77 (13_Supplement): LB-110.
Published: 01 July 2017
Marianne S. Poruchynsky, Edina Komlodi-Pasztor, Julia Wilkerson, Shana Trostel, Mauricio Burroto-Pichun, Tito Fojo
Cancer Res (2014) 74 (19_Supplement): LB-106.
Published: 01 October 2014
Abstract 4547: Treatment of human medullary thyroid carcinoma (MTC) with either proteasome (Pr) or histone deacetylase (HDAC) inhibitors leads to a fall in RET mRNA levels and, in turn, a decrease in RET protein expression providing alternate strategies to reduce RET expression in a tyrosine-kinase driven disease
Cancer Res (2011) 71 (8_Supplement): 4547.
Published: 15 April 2011
Cancer Res (2010) 70 (14): 5870–5879.
Published: 14 July 2010
Includes: Supplementary data
Frank Loganzo, Carolyn M. Discafani, Tami Annable, Carl Beyer, Sylvia Musto, Malathi Hari, Xingzhi Tan, Carolyn Hardy, Richard Hernandez, Michelle Baxter, Thiruvikraman Singanallore, Gulnaz Khafizova, Marianne S. Poruchynsky, Tito Fojo, James A. Nieman, Semiramis Ayral-Kaloustian, Arie Zask, Raymond J. Andersen, Lee M. Greenberger
Cancer Res (2003) 63 (8): 1838–1845.
Published: 15 April 2003